Skip to content

Author

Yanran Wu

We have 1 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Drug repurposing-guided discovery of novel methyl quinoline-6-carboxylate RIPK3 inhibitors through structural optimization of Gefitinib.

Overall, this study identifies Gefitinib as a novel RIPK3-targeting scaffold and demonstrates that structure-guided optimization of an EGFR inhibitor can yield potent and selective RIPK3-directed anti-necroptotic agents.

Ying Shi, Guojing Tao, Rui-Xia Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.